메뉴 건너뛰기




Volumn 172, Issue 6, 2016, Pages 841-854

Current standard treatment of adult acute promyelocytic leukaemia

Author keywords

Acute promyelocytic leukaemia; All trans retinoic acid; Arsenic trioxide; PML RARA

Indexed keywords

AIDA 0493; ANTHRACYCLINE; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; ANTINEOPLASTIC AGENT; ARSENIC; ARSENIC TRIOXIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; FIBRINOGEN; FRESH FROZEN PLASMA; GEMTUZUMAB OZOGAMICIN; HEPARIN; IDARUBICIN; RETINOIC ACID; RETINOID TAMIBAROTENE; STEROID; TAMIBAROTENE; TRANEXAMIC ACID; UNCLASSIFIED DRUG; ORGANOARSENIC DERIVATIVE; OXIDE;

EID: 84960117817     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13890     Document Type: Review
Times cited : (61)

References (80)
  • 4
    • 0037902046 scopus 로고    scopus 로고
    • Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia
    • Au, W.Y., Kumana, C.R., Kou, M., Mak, R., Chan, G.C., Lam, C.W. & Kwong, Y.L. (2003) Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia. Blood, 102, 407-408.
    • (2003) Blood , vol.102 , pp. 407-408
    • Au, W.Y.1    Kumana, C.R.2    Kou, M.3    Mak, R.4    Chan, G.C.5    Lam, C.W.6    Kwong, Y.L.7
  • 6
    • 0029819203 scopus 로고    scopus 로고
    • AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) pilot study
    • Avvisati, G., Lo-Coco, F., Diverio, D., Falda, M., Ferrara, F., Lazzarino, M., Russo, D., Petti, M.C. & Mandelli, F. (1996) AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) pilot study. Blood, 88, 1390-1398.
    • (1996) Blood , vol.88 , pp. 1390-1398
    • Avvisati, G.1    Lo-Coco, F.2    Diverio, D.3    Falda, M.4    Ferrara, F.5    Lazzarino, M.6    Russo, D.7    Petti, M.C.8    Mandelli, F.9
  • 8
    • 0015605395 scopus 로고
    • Acute promyelocytic leukemia: results of treatment by daunorubicin
    • Bernard, J., Weil, M., Boiron, M., Jacquillat, C., Flandrin, G. & Gemon, M.F. (1973) Acute promyelocytic leukemia: results of treatment by daunorubicin. Blood, 41, 489-496.
    • (1973) Blood , vol.41 , pp. 489-496
    • Bernard, J.1    Weil, M.2    Boiron, M.3    Jacquillat, C.4    Flandrin, G.5    Gemon, M.F.6
  • 10
    • 84901448095 scopus 로고    scopus 로고
    • Thrombo-hemorrhagic deaths in acute promyelocytic leukemia
    • Breccia, M. & Lo-Coco, F. (2014) Thrombo-hemorrhagic deaths in acute promyelocytic leukemia. Thrombosis Research, 133, 112-116.
    • (2014) Thrombosis Research , vol.133 , pp. 112-116
    • Breccia, M.1    Lo-Coco, F.2
  • 11
    • 77952300646 scopus 로고    scopus 로고
    • Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation
    • Breccia, M., Latagliata, R., Cannella, L., Minotti, C., Meloni, G. & Lo-Coco, F. (2010) Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation. Haematologica, 95, 853-854.
    • (2010) Haematologica , vol.95 , pp. 853-854
    • Breccia, M.1    Latagliata, R.2    Cannella, L.3    Minotti, C.4    Meloni, G.5    Lo-Coco, F.6
  • 12
    • 80052385057 scopus 로고    scopus 로고
    • Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia
    • Breccia, M., Cicconi, L., Minotti, C., Latagliata, R., Giannì, L. & Lo-Coco, F. (2011) Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia. Haematologica, 96, 1390-1391.
    • (2011) Haematologica , vol.96 , pp. 1390-1391
    • Breccia, M.1    Cicconi, L.2    Minotti, C.3    Latagliata, R.4    Giannì, L.5    Lo-Coco, F.6
  • 13
    • 84876120195 scopus 로고    scopus 로고
    • Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial
    • Burnett, A.K., Hills, R.K., Grimwade, D., Jovanovic, J.V., Craig, J., McMullin, M.F., Kell, J., Wheatley, K., Yin, J.A., Hunter, A., Milligan, D. & Russell, N.H.; United Kingdom National Cancer Research Institute Acute Myeloid Leukaemia Subgroup. (2013) Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial. Leukemia, 27, 843-851.
    • (2013) Leukemia , vol.27 , pp. 843-851
    • Burnett, A.K.1    Hills, R.K.2    Grimwade, D.3    Jovanovic, J.V.4    Craig, J.5    McMullin, M.F.6    Kell, J.7    Wheatley, K.8    Yin, J.A.9    Hunter, A.10    Milligan, D.11    Russell, N.H.12
  • 15
    • 84861346428 scopus 로고    scopus 로고
    • Bleeding and thrombosis in acute promyelocytic leukemia
    • Choudhry, A. & DeLoughery, T.G. (2012) Bleeding and thrombosis in acute promyelocytic leukemia. American Journal of Hematology, 87, 596-603.
    • (2012) American Journal of Hematology , vol.87 , pp. 596-603
    • Choudhry, A.1    DeLoughery, T.G.2
  • 17
    • 33646386643 scopus 로고    scopus 로고
    • Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia
    • Estey, E., Garcia-Manero, G., Ferrajoli, A., Faderl, S., Verstovsek, S., Jones, D. & Kantarjian, H. (2006) Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia. Blood, 107, 3469-3473.
    • (2006) Blood , vol.107 , pp. 3469-3473
    • Estey, E.1    Garcia-Manero, G.2    Ferrajoli, A.3    Faderl, S.4    Verstovsek, S.5    Jones, D.6    Kantarjian, H.7
  • 18
    • 0027368561 scopus 로고
    • Effect of all trans-retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group
    • Fenaux, P., Le Deley, M.C., Castaigne, S., Archimbaud, E., Chomienne, C., Link, H., Guerci, A., Duarte, M., Daniel, M.T. & Bowen, D. (1993) Effect of all trans-retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood, 82, 3241-3249.
    • (1993) Blood , vol.82 , pp. 3241-3249
    • Fenaux, P.1    Le Deley, M.C.2    Castaigne, S.3    Archimbaud, E.4    Chomienne, C.5    Link, H.6    Guerci, A.7    Duarte, M.8    Daniel, M.T.9    Bowen, D.10
  • 20
    • 77958580267 scopus 로고    scopus 로고
    • Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission
    • Ferrara, F., Finizio, O., Izzo, T., Riccardi, C., Criscuolo, C., Carbone, A., Borlenghi, E. & Rossi, G. (2010) Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission. Anticancer Research, 30, 3845-3849.
    • (2010) Anticancer Research , vol.30 , pp. 3845-3849
    • Ferrara, F.1    Finizio, O.2    Izzo, T.3    Riccardi, C.4    Criscuolo, C.5    Carbone, A.6    Borlenghi, E.7    Rossi, G.8
  • 21
    • 0026647140 scopus 로고
    • The "retinoic acid syndrome" in acute promyelocytic leukemia
    • Frankel, S.R. (1992) The "retinoic acid syndrome" in acute promyelocytic leukemia. Annals of Internal Medicine, 117, 292-296.
    • (1992) Annals of Internal Medicine , vol.117 , pp. 292-296
    • Frankel, S.R.1
  • 24
    • 0032853710 scopus 로고    scopus 로고
    • The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease
    • Grimwade, D. (1999) The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease. British Journal of Haematology, 106, 591-613.
    • (1999) British Journal of Haematology , vol.106 , pp. 591-613
    • Grimwade, D.1
  • 25
    • 0023752982 scopus 로고
    • Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
    • Huang, M.E., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhoa, L., Gu, L.J. & Wang, Z.Y. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-572.
    • (1988) Blood , vol.72 , pp. 567-572
    • Huang, M.E.1    Ye, Y.C.2    Chen, S.R.3    Chai, J.R.4    Lu, J.X.5    Zhoa, L.6    Gu, L.J.7    Wang, Z.Y.8
  • 30
    • 84857994331 scopus 로고    scopus 로고
    • Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia
    • Lengfelder, E., Hofmann, W.K. & Nowak, D. (2012) Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia. Leukemia, 26, 433-442.
    • (2012) Leukemia , vol.26 , pp. 433-442
    • Lengfelder, E.1    Hofmann, W.K.2    Nowak, D.3
  • 35
    • 84902304171 scopus 로고    scopus 로고
    • Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy
    • Lou, Y., Suo, S., Tong, Y., Tong, H., Qian, W., Meng, H., Mai, W., Huang, J., Yu, W. & Jin, J. (2014) Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy. Annals of Hematology, 93, 941-948.
    • (2014) Annals of Hematology , vol.93 , pp. 941-948
    • Lou, Y.1    Suo, S.2    Tong, Y.3    Tong, H.4    Qian, W.5    Meng, H.6    Mai, W.7    Huang, J.8    Yu, W.9    Jin, J.10
  • 41
    • 84960188995 scopus 로고    scopus 로고
    • NCCN guidelines "Acute myeloid leukemia", version 1.2015. National Comprehensive Cancer Network, Fort Washington, PA. Available at:. [Accessed December 3, 2014].
    • NCCN (2015) NCCN guidelines "Acute myeloid leukemia", version 1.2015. National Comprehensive Cancer Network, Fort Washington, PA. Available at: http://www.nccn.org/professionals/physician_gls/pdf/aml.pdf. [Accessed December 3, 2014].
    • (2015)
  • 42
    • 35348907310 scopus 로고    scopus 로고
    • PML-RARalpha inhibitors (ATRA, tamibarotene, arsenic trioxide) for acute promyelocytic leukemia
    • Ohnishi, K. (2007) PML-RARalpha inhibitors (ATRA, tamibarotene, arsenic trioxide) for acute promyelocytic leukemia. International Journal of Clinical Oncology, 12, 313-317.
    • (2007) International Journal of Clinical Oncology , vol.12 , pp. 313-317
    • Ohnishi, K.1
  • 44
    • 0041327727 scopus 로고    scopus 로고
    • Expression of cell-surface antigens in acute promyelocytic leukaemia
    • Paietta, E. (2003) Expression of cell-surface antigens in acute promyelocytic leukaemia. Best Practice Research in Clinical Haematology, 16, 369-385.
    • (2003) Best Practice Research in Clinical Haematology , vol.16 , pp. 369-385
    • Paietta, E.1
  • 56
    • 79952079063 scopus 로고    scopus 로고
    • Modern approaches to treating acute promyelocytic leukemia
    • Sanz, M.A. & Lo-Coco, F. (2011) Modern approaches to treating acute promyelocytic leukemia. Journal of Clinical Oncology, 29, 495-503.
    • (2011) Journal of Clinical Oncology , vol.29 , pp. 495-503
    • Sanz, M.A.1    Lo-Coco, F.2
  • 69
    • 3042629830 scopus 로고    scopus 로고
    • Curative therapeutic approaches to APL
    • Tallman, M.S. (2004) Curative therapeutic approaches to APL. Annals of Hematology, 83, S81-S82.
    • (2004) Annals of Hematology , vol.83 , pp. S81-S82
    • Tallman, M.S.1
  • 70
    • 73949097021 scopus 로고    scopus 로고
    • How I treat acute promyelocytic leukemia
    • Tallman, M.S. & Altman, J.K. (2009) How I treat acute promyelocytic leukemia. Blood, 114, 5126-5135.
    • (2009) Blood , vol.114 , pp. 5126-5135
    • Tallman, M.S.1    Altman, J.K.2
  • 72
    • 77958510339 scopus 로고    scopus 로고
    • Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
    • de Thé, H. & Chen, Z. (2010) Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nature Reviews Cancer, 10, 775-783.
    • (2010) Nature Reviews Cancer , vol.10 , pp. 775-783
    • de Thé, H.1    Chen, Z.2
  • 73
    • 84865074686 scopus 로고    scopus 로고
    • The cell biology of disease: acute promyelocytic leukemia, arsenic, and PML bodies
    • de Thé, H., Le Bras, M. & Lallemand-Breitenbach, V. (2012) The cell biology of disease: acute promyelocytic leukemia, arsenic, and PML bodies. Journal of Cell Biology, 198, 11-21.
    • (2012) Journal of Cell Biology , vol.198 , pp. 11-21
    • de Thé, H.1    Le Bras, M.2    Lallemand-Breitenbach, V.3
  • 74
    • 70350621606 scopus 로고    scopus 로고
    • Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen
    • Thirugnanam, R., George, B., Chendamarai, E., Lakshmi, K.M., Balasubramanian, P., Viswabandya, A., Srivastava, A., Chandy, M. & Mathews, V. (2009) Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen. Biology of Blood Marrow Transplantation, 15, 1479-1484.
    • (2009) Biology of Blood Marrow Transplantation , vol.15 , pp. 1479-1484
    • Thirugnanam, R.1    George, B.2    Chendamarai, E.3    Lakshmi, K.M.4    Balasubramanian, P.5    Viswabandya, A.6    Srivastava, A.7    Chandy, M.8    Mathews, V.9
  • 76
    • 41949111045 scopus 로고    scopus 로고
    • Acute promyelocytic leukemia: from highly fatal to highly curable
    • Wang, Z.Y. & Chen, Z. (2008) Acute promyelocytic leukemia: from highly fatal to highly curable. Blood, 111, 2505-2515.
    • (2008) Blood , vol.111 , pp. 2505-2515
    • Wang, Z.Y.1    Chen, Z.2
  • 77
    • 80051473507 scopus 로고    scopus 로고
    • The efficacy and safety of arsenic trioxide with or without all-trans retinoic acid for the treatment of acute promyelocytic leukemia: a meta-analysis
    • Wang, H., Chen, X.Y., Wang, B.S., Rong, Z.X., Qi, H. & Chen, H.Z. (2011) The efficacy and safety of arsenic trioxide with or without all-trans retinoic acid for the treatment of acute promyelocytic leukemia: a meta-analysis. Leukemia Research, 35, 1170-1177.
    • (2011) Leukemia Research , vol.35 , pp. 1170-1177
    • Wang, H.1    Chen, X.Y.2    Wang, B.S.3    Rong, Z.X.4    Qi, H.5    Chen, H.Z.6
  • 79
    • 84918789988 scopus 로고    scopus 로고
    • Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia
    • Zhu, H.H. & Huang, X.J. (2014) Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia. New England Journal of Medicine, 371, 2239-2241.
    • (2014) New England Journal of Medicine , vol.371 , pp. 2239-2241
    • Zhu, H.H.1    Huang, X.J.2
  • 80
    • 84892940228 scopus 로고    scopus 로고
    • Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenictrioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial
    • Zhu, H.H., Wu, D.P., Jin, J., Li, J.Y., Ma, J., Wang, J.X., Jiang, H., Chen, S.J. & Huang, X.J. (2013) Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenictrioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. Journal of Clinical Oncology, 31, 4215-4221.
    • (2013) Journal of Clinical Oncology , vol.31 , pp. 4215-4221
    • Zhu, H.H.1    Wu, D.P.2    Jin, J.3    Li, J.Y.4    Ma, J.5    Wang, J.X.6    Jiang, H.7    Chen, S.J.8    Huang, X.J.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.